The largest long position in CRCL incurred a loss of $1.099 million, holding a $6.936 million position with 10x leverage on Hyperliquid.

iconKuCoinFlash
Share
AI summary iconSummary
A large long position in CRCL on Hyperliquid has lost $1.099 million, with a position size of $6.936 million using 10x leverage. The position was opened at $98.20, with an isolated margin of $1.255 million and a liquidation price at $73.10. Two buy orders at $86 and $85 added $200,000 to the position. Four additional buy orders between $81 and $84 totaled $400,000. The U.S. Senate’s CLARITY Act procedural vote failed 49–50. CRCL closed at $86.30 on September 15, down 11.41%.

Odaily Planet Daily report: The average holding price of this position is $98.20, with a isolated margin balance of approximately $1.255 million and a liquidation price of $73.10, about 13.8% below the current price. Two buy orders at $86 and $85 have been filled, adding a total of approximately $200,000 in long exposure. Currently, four additional buy orders remain unfilled between $81 and $84, each at approximately $100,000, with a combined pending amount of about $400,000.

The U.S. Senate previously held a procedural vote on advancing the CLARITY Act, resulting in 49 votes in favor and 50 against, failing to reach the three-fifths threshold, and the motion to proceed was not approved. CRCL closed at $86.30 on September 15, down 11.41% for the day.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.